More than 35 000 umbilical cord blood (UCB) transplants have been performed worldwide, prompting the development of private and public banks to collect and store UCB cells. We hypothesized that pediatricians, who are uniquely poised to discuss UCB banking (UCBB) during prenatal or sibling visits, rarely do so. Through distribution of a 26-question electronic survey to general and subspecialty pediatric providers, we assessed baseline knowledge and conversations about UCBB. A total of 473 providers completed the survey; only 22% of physicians ever discussed UCBB with expectant parents. The majority responded that autologous UCB transplants were indicated in malignant (73%) and nonmalignant (61%) conditions; however, these are rare indications. Providers practicing >10 years were more likely to address UCBB (P ≤ .001), whereas younger and female general pediatric providers were significantly less likely (P < .001). Overall, pediatric providers rarely speak to families about UCBB, and we believe that they can be better informed to its current clinical utility.
Introduction
Over the past 25 years, great progress has been made in the field of stem cell transplantation, especially in regard to patient selection, modification of conditioning regimen, and choice of the umbilical cord blood (UCB) as a stem cell donor source for UCB transplantation (UCBT). UCB has been predominantly used as a source of allogeneic hematopoietic stem cells in the treatment of malignant and nonmalignant blood disorders, but emerging indications for allogeneic and autologous UCB cells in cellular regenerative therapy and immune modulation, such as in cerebral palsy, neonatal hypoxic-ischemic encephalopathy, and diabetes, are being explored. 1 Improved outcomes in the current era, less stringent requirements for human leukocyte antigen (HLA) matching, and quick availability have led to a dramatic increase in allogeneic UCBT, with more than 35 000 UCBTs being performed to date. 2 There is an ever rising demand for high-quality UCB units, which are stored between public banks, which keep units for any patient in need, and private banks, which store UCB units for the use of the banking family. Currently, approximately 730 000 UCB units have been stored in more than 160 public UCB banks, whereas more than 4 million UCB units are stored by the private sector in approximately 215 private banks. 3, 4 The current American Academy of Pediatrics (AAP) recommendation is that physicians be familiar with the rationale for UCB banking (UCBB) and with the types of cord blood banking programs available. 5 The majority of education about UCBB is conducted by obstetricians, however, and when nearing delivery obstetrical care takes priority and cord blood banking, whether public or private, is not always thoroughly explored. 6 It should, therefore, be the responsibility of not only the obstetricians but also other physicians, such as the primary care pediatricians who potentially see parents prior to the delivery day, to review the purpose and importance of UCBB. Although the role of obstetricians is commonly described, 7, 8 there is little data on the primary pediatrician's role in UCBB. We sought to determine the knowledge base, experience, and attitudes of medical providers within the field of pediatrics pertaining to UCBB, hypothesizing that the more knowledgeable providers who speak about UCBB would be newer graduates into the field, who have received formal education about UCBB.
Methods

Study Design and Participants
We conducted an institutional review board-approved electronic survey among pediatric medical providers between October 2014 and March 2015. These included medical students, residents, advanced nurse practitioners, subspecialists, hospitalists, academic general pediatricians, and private practice pediatricians affiliated with the Ann and Robert H. Lurie Children's Hospital of Chicago. Additionally, we distributed the survey to the Section of Young Physician membership through the AAP, which included pediatric providers who had completed training and a smaller portion who were still in training. Participation was voluntary and estimated at 5 minutes for completion with a $5.00 compensatory gift card. The questionnaire was composed of 26 questions, including dichotomous, multiple-choice answers, and rating using the Likert scale method, along with a blank comment section at the end of the questionnaire. Certain answer choices were not mutually exclusive, and some participants were filtered past questions if the content was not applicable. Members from the Department of Medical Social Sciences at Northwestern University and the National Marrow Donor Program reviewed the questions for quality and reproducibility before finalization and distribution of the questionnaire.
Study Variables
Knowledge of UCBT and UCBB Practices. To assess baseline knowledge of participants, we inquired as to if and where they had received formal education about UCBB (see Supplemental Figure to view questionnaire, available at http://clp.sagepub.com/supplemental). We then determined what participants believed were indications for UCBT, providing the following possible answer choices: autologous transplant for malignant conditions, autologous transplant for nonmalignant conditions, allogeneic transplant for malignant conditions, and allogeneic transplant for nonmalignant conditions; the definitions of autologous and allogeneic were provided (own and other, respectively) along with categories of nonmalignant conditions (genetic/metabolic, hematological, and immunological conditions). Finally, we examined topics in which participants would be interested in receiving additional information, providing 8 different areas in addition to an "other" option.
Specifics About UCBB. We attempted to evaluate details regarding discussions about UCBB. Areas addressed were level of comfort, how often, at what point during pregnancy (based on trimester), and for which indications (potential use for unrelated recipients, child's family members, child, or other). In addition, we tried to determine why some participants did not discuss UCBB by providing possible answer choices in addition to an "other" option. Finally, conversations pertaining to private and public cord blood banks were assessed in those that did address UCBB, including providers' knowledge in regard to the cost.
Covariates
Demographic factors, including age, gender, years of practice, career stage, and, if applicable, subspecialty of practice, were obtained through self-report. For the variables of age and years of practice, ranges in years were provided for selection.
Statistical Analysis
Survey responses were recorded as a frequency distribution. The main dependent variables in our study were questions related to knowledge of UCBT and frequency of communication with expecting parents about UCBB; responses within these variables were further compared against one another. To detect differences between those who spoke with families about UCBB and those who did not, we assessed demographic variables using the Pearson χ 2 test for discrete variables and the KruskalWallis test for continuous variables, with significance set at P < .05.
Results
Baseline Characteristics of Participants
Of the approximately 2400 providers contacted a maximum of 2 times, 481 (20%) completed the questionnaire; 8 responses were excluded (1 for duplicative entry, 7 for providers not in our intended demographic for career stage). Table 1 shows the baseline demographics of the 473 providers included in our results. Respondents were predominantly general private pediatricians (31%), female (76%), younger (57% were 30-39 years of age), and newer to the field (37% practicing <5 years). For those subspecialty fellow and attending physicians who participated, 22% were from neonatology, 18% from hematology/oncology/stem cell transplant, 12% from allergy/immunology, and the remaining 48% from a variety of other subspecialties, including 5 identified subspecialty attending physicians who did not list a specific subspecialty.
Baseline Knowledge of Participants
Only 50 of 473 respondents (11%) had received formal education about UCBB, mainly during residency. Of our participants, the majority felt that UCB cells could be used for autologous transplant in both malignant (73%) and nonmalignant (61%) conditions. Additionally, some providers did not indicate that UCB cells were appropriate for allogeneic transplant of malignant and nonmalignant conditions. More than 90% requested additional information about UCBB and UCBT, predominantly regarding conditions treated by and benefits of UCBT, along with better understanding of the cost and donation process of UCBB. See Table 2 for complete results.
Conversations About UCBB
Of the 473 providers surveyed, the large majority did not speak to parents about UCBB (79%). The most common barriers to conversations included inadequate education about UCBB (n = 250) and lack of opportunity to discuss before the infant's birth (n = 240). Less frequently identified reasons were lack of interest from expecting parents (n = 63) or from providers (n = 31).
It was found that 36% of providers who received formal education about UCBB spoke with families regarding UCBB in comparison to 18% of providers who never received formal education (P = .004). Excluding trainees who were unlikely to have the chance to speak with families about UCBB -namely, medical students, pediatric residents, and advanced nursing practitioners -there were only 85 (22%) of the remaining 377 who discussed UCBB with expectant parents. The majority of providers who spoke to expectant parents about UCBB were general private pediatricians. Furthermore, we found that conversations about UCBB rarely occurred but when they did, they mostly happened during the third trimester of pregnancy. Providers were most likely to mention the potential indication of UCB cells for both autologous and related indications (71%) and less likely to have addressed use for unrelated recipients (62%). Of those who discussed UCBB with families, many providers believed that autologous UCBT is suitable for treatment of malignant (66%) and nonmalignant (55%) conditions. Expectant parents were more likely to mention private banking, whereas medical providers more likely mentioned public banking (Figure 1) . Providers who discussed UCBB always or often encouraged public UCBB (41%) and rarely or never supported private UCBB (75%). Those who encouraged private UCBB did so mostly as part of a sibling or close relative donor program (42%) or for the potential use of a child's own future indications (29%). On the other hand, if public UCBB was encouraged, providers noted that they predominantly did so for the ability to help unrelated patients (73%) ( Table 3) . Most providers felt somewhat knowledgeable regarding the cost of private and public UCBB (44% and 41%, respectively).
Pediatric providers practicing for longer periods of time (>10 years) were more likely to discuss UCBB (P < .001 for general pediatric providers and P = .001 for subspecialty providers). Years of practice moderated age or gender differences in initiation of UCBB discussions. Within the subspecialty providers, those in the field of hematology, oncology, and stem cell transplantation had more frequent discussions (P < .001) ( Table 4) .
Comments About UCBB
Overall, we found that participants of various career stages expressed interest in learning more about UCBB and how it could impact not only their patients, but also their own families and peers.
Discussion
Since the first UCBT in 1988, recognizing the need for a reliable, cost-effective source of HLA-diverse, quality-controlled, and ethically sourced cord blood units for transplantation, there has been considerable growth of UCBB. 2, 3, 9 Alongside the increased medical use, there has been a growing body of research on the potential use of cord blood cells for the treatment of both hematopoietic and nonhematopoietic diseases. 1, 3, 10 Of particular interest is the use of cord blood cells to generate multipotent stem cells, leading several to investigate the expanded possibility of cord blood in the development of novel therapies, especially for regenerative medicine. 1, 11 At present, more than 160 public UCBB banks have been established worldwide, and there are approximately 730 000 UCB units available for public use. 3, 4 Expectant families may electively donate their infant's UCB to one of these public banks, and the UCB is banked and listed on a donor registry if certain donor-screening criteria are met. Private cord blood banks, which store UCB units for personal use, usually for an up-front and yearly fee, have an impressive estimated 4 million UCB units stored. Although the amount of cord blood inventory in private banks worldwide is approximately 6 times more than in public banks, the public banks have released 30 times more units for therapy (30 000 vs 1000).
3 Current practice for delivering information regarding UCBB is focused heavily on obstetricians who are primarily responsible for the collection. 7, 8 We believe that primary care pediatricians in their role as caregivers for the siblings of expecting parents and in the increasingly popular prenatal visit are uniquely poised to address critical knowledge deficits regarding UCBB.
We sought to assess the role of pediatric providers in UCBB practices at our center, a large tertiary academic institution affiliated with a women's hospital, responsible for more than 13 000 births per year, along with those affiliated with the AAP. Overall, we found that teaching of UCBB practices is infrequent in pediatric training programs because approximately 90% of our participants lacked formal education about UCBB; however, we acknowledge that we did not address self-directed informal education. Furthermore, we believe that many pediatric providers are unclear as to the utility of UCBT, similar to obstetricians who are generally familiar with the role of donated cord blood but could benefit from additional information regarding how cord blood is used in transplantation. 12 Although our surveyed cohort believed that autologous use of UCB was a main indication for UCBT, the likelihood that stored UCB units can be used for autologous purposes is extremely low, with current estimates ranging from 1 in 2500 (0.04%) to 1 in 200 000 (0.0005%). 13, 14 Of our study participants, 73% felt that autologous UCBT occurs in malignant conditions, and 61% felt that it occurs in nonmalignant conditions, outlined as genetic/metabolic, hematological and immunological diseases in our survey. Unfortunately, our assessment of autologous UCB cell use was restricted to a dichotomous answer choice, preventing us from detecting if participants were knowledgeable about the rarity of this occurrence. Specifically, in 2011, Rosenthal et al 15 reported that in the 2 largest privately owned cord blood banks in the United States, more than 355 000 UCB units were collected, and between the two, 107 units were released, with 30 (0.008%) used for autologous UCBT. The majority of these autologous units were used for 3 Regarding use in life-threatening diseases, documented successful case reports have involved treatment of neuroblastoma, 16 aplastic anemia, 15, 17 and acute lymphoblastic leukemia, 18 although this is not standard practice. Though autologous use of cells is promising, it remains experimental, and current proven use of UCBT is in allogeneic transplant for malignant and nonmalignant disorders. 14 We believe that most providers are misinformed and likely unaware of the extremely uncommon indication for autologous UCBT.
In our surveyed population, very few providers were instigating conversations about UCBB. Providers' barriers to discussing UCBB mostly included inadequate education and lack of opportunity to hold a conversation before the infant was born. We did find that pediatric providers practicing for more than 10 years were significantly more likely to discuss UCBB compared with their younger colleagues, probably reflecting continued parental questioning and experience gained over years of practice. Although public banking was encouraged, the ability to help unrelated patients with a product that might otherwise be discarded was not routinely discussed.
Private umbilical cord banks are more widely advertised, from the obstetrical waiting rooms 19 to Internet search engine results, and as expected, providers in our survey found that parents were more likely to address private banks when discussing UCBB, although private banking was not often encouraged. There are concerns that commercial private banks exploit the emotional vulnerabilities of parents and do not adequately inform parents of the low chance of use, of alternative sources of available stem cells (eg, autologous peripheral blood), or of the risks of reducing stocks of allogeneic hematopoietic stem cells in public UCB banks. 20 Overall, there is a much greater need for UCB units in allogeneic transplant. The majority of UCB units, however, are stored by the private sector and unavailable for public use. The lack of emphasis on public donation significantly affects the general population, who may benefit from a matched or nearly matched UCBT, specifically the minority populations who are underrepresented in the National Marrow Donor Program.
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Conclusion
The AAP, the American Association of Obstetrics and Gynecology, and the American Society for Blood and Marrow Transplantation recommend public donation of UCB units unless there is a medical indication for autologous or related cord blood transplantation in the donor's family. 5, 13, 22 We demonstrate in our survey that pediatric providers need further education to address the basics of UCBB and UCBT, which would also help overcome the commonly identified barrier of inadequate education toward initiating discussions with families. Conversations about UCBB with expectant families need to occur more often, and public donation should be emphasized unless family-directed donation is warranted. Surveyed providers at all levels of training are more interested in learning about UCBB and the rationale for UCBT. As the field of UCBT and regenerative therapies continues to grow, pediatric providers are a vital, yet underused, resource toward guiding expectant families in UCBB.
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